chr8-68331069-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052958.4(C8orf34):āc.57C>Gā(p.Phe19Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000692 in 1,445,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_052958.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C8orf34 | NM_052958.4 | c.57C>G | p.Phe19Leu | missense_variant | 1/14 | ENST00000518698.6 | |
C8orf34-AS1 | NR_038877.1 | n.185+238G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C8orf34 | ENST00000518698.6 | c.57C>G | p.Phe19Leu | missense_variant | 1/14 | 2 | NM_052958.4 | P2 | |
C8orf34-AS1 | ENST00000660308.1 | n.205+238G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000137 AC: 2AN: 145484Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000464 AC: 4AN: 86286Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 49206
GnomAD4 exome AF: 0.0000754 AC: 98AN: 1300198Hom.: 0 Cov.: 31 AF XY: 0.0000764 AC XY: 49AN XY: 641344
GnomAD4 genome AF: 0.0000137 AC: 2AN: 145484Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 71080
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.57C>G (p.F19L) alteration is located in exon 1 (coding exon 1) of the C8orf34 gene. This alteration results from a C to G substitution at nucleotide position 57, causing the phenylalanine (F) at amino acid position 19 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at